ForumIAS announcing GS Foundation Program for UPSC CSE 2025-26 from 19 April. Click Here for more information.
ForumIAS Answer Writing Focus Group (AWFG) for Mains 2024 commencing from 24th June 2024. The Entrance Test for the program will be held on 28th April 2024 at 9 AM. To know more about the program visit: https://forumias.com/blog/awfg2024
Contents
Source: Indian Express
What is the News?
Zydus Cadila has applied to Central Drugs Standard Control Organisation (CDSCO) seeking emergency use authorisation (EUA) for ZyCov-D, its Covid-19 vaccine. If approved by the regulator, ZyCov-D will be the world’s first DNA vaccine against infection with SARS-CoV-2.
What is ZyCov-D Vaccine?
- ZyCov-D is a plasmid DNA vaccine, which means it uses a genetically engineered, non-replicating version of a type of DNA molecule known as a ‘plasmid’.
- Developed by: ZyCov-D has been developed by Zydus Cadila with the support of the Department of Biotechnology and the Indian Council of Medical Research (ICMR).
How does the ZyCov-D vaccine work?
- In this vaccine, the plasmids are coded with the instructions to make the spike protein of SARS-CoV-2, the coronavirus that causes Covid-19.
- Vaccination gives the code to cells in the recipient’s body, so they can begin making the spiky outer layer of the virus.
- The immune system is expected to recognize this as a threat and develop antibodies in response.
How will the ZyCov-D be given?
- Most Covid-19 vaccines currently are given in two doses. In contrast, ZyCov-D will be given in three doses, with an interval of 28 days between each dose.
- Moreover, ZyCov-D is also an intradermal vaccine which means it is applied using a ‘needle-free injector’. Instead, a spring-powered device delivers the shot as a narrow, precise stream of fluid that penetrates the skin.
